Results of international trial show promise in rare, difficult to treat cancer: results from the RADIANT-4 trial

February 03, 2022 By wadmin

Results of international trial show promise in rare, difficult to treat cancer: results from the RADIANT-4 trial Neuroendocrine tumours (NETs) develop in the neuroendocrine system, responsible for producing the hormones that regulate the working of different organs in the body. They are rare, incurable, and treatments for them are limited...

Read More

Lung cancer survival rates improve with CT scan follow-up

February 03, 2022 By wadmin

Patients with recurrent lung cancer have better post-surgery survival rates if their management includes a follow-up programme based on computer tomography (CT) of the chest, according to new findings. The findings, presented at the ERS International Congress 2015 in Amsterdam today (27 September, 2015), is the first to show improved...

Read More

Request a Refill

10 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.